About Us
Training
Research
Harm Reduction
Integration Support
5-MeO-DMT Information
5-MeO-DMT Information · Comparison

Bufo vs Synthetic 5-MeO-DMT: The Real Differences The FIVE Institute

Bufo vs Synthetic 5-MeO-DMT.
The Real Differences.

Topics covered: Source · Purity · Dosing
Experience · Safety · Conservation · Legality
Compare Side by Side →Toad Conservation →

Reviewed by The FIVE Institute · Last reviewed

Disclaimer: 5-MeO-DMT is a Schedule I controlled substance in the United States and is regulated in many jurisdictions. This page is educational and does not condone or encourage its use.

Introduction

A Question of
Source, Not Effect

Fig. 2 · 5-Methoxy-N,N-dimethyltryptamine

The same molecule, whether from toad secretion or the laboratory

Bufo vs synthetic 5-MeO-DMT is a question of source, not effect: both forms deliver the same active molecule, and senior facilitators who have worked with each report a nearly identical peak experience. The differences lie elsewhere, dried toad secretion contains 10–30% 5-MeO-DMT alongside dozens of other compounds, including bufotenin and heart-active bufadienolides, while synthetic material is a single compound, 99%+ pure when pharmaceutical-grade, with exact dosing.1Laboratory study

The choice also carries an ecological cost. As toad-derived 5-MeO-DMT spreads globally, demand for the secretion is placing growing pressure on wild Sonoran Desert toad populations. Researchers including Ana María Ortiz Bernal and colleagues2Review have examined how claims of ancestral use are used to market the secretion, and the ecological politics that follow. Synthetic material removes that pressure entirely.

Risks & Cautions →Toad Conservation →About 5-MeO-DMT →
What Each Form Is

Two Routes, One Molecule

Before comparing, be clear on what each form actually is.

Bufo alvarius secretion

The Sonoran Desert toad (Incilius alvarius) produces a defensive venom in its parotoid glands, not a compound made for human use. Milked and dried, the secretion contains 10–30% 5-MeO-DMT plus other tryptamines and alkaloids, including bufotenin and bufotalin.3Analytical study Lab testing has found bufotenin, the only other psychedelic compound present, in amounts too small to plausibly affect the experience; the remaining alkaloids add cardiovascular load, not benefit.

Synthetic 5-MeO-DMT (“The Pure Molecule” or “Jaguar”)

First synthesized in 1936 by Hoshino and Shimodaira, decades before its effects were known. A white-to-beige crystalline powder at 99%+ purity when pharmaceutical-grade (street material varies): one compound, no additional alkaloids, and a milligram is always a milligram. It is the form used in clinical research, where knowing the exact dose is a requirement. In addition, synthetic 5-MeO-DMT use predates the use of bufo secretion.
Conservation

Ethics & Conservation

Demand for the secretion is rising while the toad population declines.
That asymmetry is the strongest argument in this comparison.

Local communities and conservationists report declining populations in parts of the toad’s range, driven by collection pressure, habitat loss, vehicles, and pesticides; it is believed extinct in California and listed as threatened in New Mexico.4Review Milking strips toads of their primary defense; bare-handed handling spreads chytrid fungus through the population; toads are held captive outside their habitats. Notably, there is no documented tradition of Indigenous peoples smoking the secretion before it was brought to them by a notable figure.2Review Modern use dates to Ken Nelson’s 1984 pamphlet, written under the name Albert Most.5Primary source

Synthetic production requires no toads and no habitat. This is why many facilitators, including The FIVE Institute’s training faculty, have moved partly or entirely to synthetic material.

Read About Toad Conservation →Read A Study on the Toad →
Nine Criteria

The Side-by-Side Comparison

Nine practical criteria, compared honestly. Where the evidence is thin, the table says so.

Bufo alvarius secretionSynthetic 5-MeO-DMT
SourceDefensive gland secretion of an at risk species.Laboratory synthesis from chemical precursors.
5-MeO-DMT content10–30% of the dried secretion, up to a threefold difference in potency between batches that are impossible to measure without a lab.99%+ purity when pharmaceutical-grade, consistent batch to batch; street material varies.
Other compoundsDozens of other compounds, including bufotenin and heart-active bufadienolides (bufotoxins act on the heart’s sodium-potassium pump, like digitalis).None.
Dosing consistencyActual dose unknowable without lab testing.Exact milligram dosing.
Peak experienceNo controlled study has compared the two directly; facilitators experienced with both report the same or a nearly identical peak.No controlled study has compared the two directly; facilitators experienced with both report the same or a nearly identical peak.
DurationRoughly 15–30 minutes when inhaled, with after-effects up to an hour.Roughly 15–30 minutes when inhaled, with after-effects up to an hour.
Cardiovascular loadHigher, additional heart-active compounds can add strain to the heart and blood pressure, especially in compromised hearts. Screening applies to both: Risks & Cautions.Limited to pure 5-MeO-DMT’s effects, still significant, but predictable. Screening applies to both: Risks & Cautions.
Conservation impactContributes to pressure on a declining species.None.
Legal considerationsFalls under 5-MeO-DMT’s status wherever it is controlled (Schedule I in the US); some jurisdictions treat the toad, the secretion, and the synthesized compound differently. Details: Legality by Country.Falls under 5-MeO-DMT’s status wherever it is controlled (Schedule I in the US); some jurisdictions treat the toad, the secretion, and the synthesized compound differently. Details: Legality by Country.
Review Screening & Risks →
Professional Training

Ethical Facilitation

Understanding both forms, their safety implications, dosing, sourcing ethics, is baseline competence for anyone serving 5-MeO-DMT professionally. The FIVE Institute’s 9-month facilitator curriculum teaches it in depth, with protocols built around lab-verified material.
Explore the Training →

Download the Info Packet

  • Program overview, structure and schedule
  • Faculty and lead teachers
  • Tuition, payment plans and what’s included
  • Admission requirements and how to apply

We respect your inbox. Unsubscribe anytime.

Questions & Answers

Bufo vs Synthetic: Common Questions

Can I mix Bufo and synthetic in the same ceremony?
It’s not recommended. Dosing becomes impossible to calculate and the potentiality of serotonin syndrome and other factors increase, safety goes out the window. Choose one form per session with a skilled facilitator.
Is one form more spiritual than the other?
No, synthesized 5-MeO-DMT and 5-MeO-DMT in the bufo secretion is identical. Both forms can offer a mystical experience, and both can fall flat without proper preparation and setting. Your serotonin receptors cannot tell toad-derived from lab-derived 5-MeO-DMT.
Is there a difference in addiction potential?
Neither form shows significant addiction potential, the experience is too intense for casual repetition. Psychological dependence on peak experiences is possible with either; integration is what prevents escapism. Repeated use without real integration can lead to ego inflation. See our FAQs on frequency of use.
Which form is used in research?
Clinical trials use synthetic, since they require knowing exactly what dose participants receive; some naturalistic studies have used toad secretion. That’s one reason the clinical evidence base is built on the pure molecule.
Key Terms

Glossary

Alkaloid
A naturally occurring, nitrogen-containing compound, often with strong effects on the body. Toad secretion contains dozens.
Bufotalin
A bufadienolide (one of the bufotoxins) in toad secretion that acts on the heart, similar to digitalis.
Bufotenin
A tryptamine closely related to 5-MeO-DMT, also found in toad secretion and some plants.
Bufotoxins
Heart-active steroids (bufadienolides) in toad secretion that act on the heart’s sodium-potassium pump, like digitalis, and can raise cardiovascular risk.
Chytrid fungus
A skin infection (Batrachochytrium dendrobatidis) devastating amphibians worldwide; it can spread through bare-handed handling.
Integration
The process of making sense of a psychedelic experience and carrying its insights into everyday life.
Parotoid gland
One of the large glands behind a toad’s eyes that release a defensive secretion. In the Sonoran Desert toad, this secretion contains 5-MeO-DMT.
Serotonin syndrome
A potentially life-threatening reaction to excess serotonin activity, usually from high doses or combining serotonin-affecting substances.
Tryptamine
A family of compounds built on an indole ring. It includes serotonin and psychedelics such as DMT, psilocybin and 5-MeO-DMT.
References
  1. [1]Sherwood, A., Claveau, R., et al. (2020). Synthesis and characterization of 5-MeO-DMT succinate for clinical use. ACS Omega. Laboratory study DOI ↗
  2. [2]Ortiz Bernal, A. M., Raison, C. L., et al. (2026). Fabricated ancestrality: The Sonoran Desert toad, psychedelic globalization, and the ecological politics of 5-MeO-DMT. Psychedelics. Review DOI ↗
  3. [3]Weil, A. T., Davis, W. (1994). Bufo alvarius: A potent hallucinogen of animal origin. Journal of Ethnopharmacology. Analytical study DOI ↗
  4. [4]Villa, R. A. (2023). Toad in the road: Biocultural history and conservation challenges of the Sonoran Desert Toad. Journal of Psychedelic Studies. Review DOI ↗
  5. [5]Most, A. (1984). Bufo alvarius: The psychedelic toad of the Sonoran Desert. Venom Press. Primary source DOI ↗

See the full scientific bibliography.

How to cite this page

The FIVE Institute. (2026, November 3). Bufo vs Synthetic 5-MeO-DMT: The Real Differences. https://five-meo.education/5-meo-dmt/bufo-vs-synthetic/

Last reviewed November 3, 2026 · Reviewed by The FIVE Institute · APA 7th edition

Fireside Support Line